These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7759863)

  • 1. Apparent split tolerance of CD8+ T cells from beta 2-microglobulin-deficient (beta 2m-/-) mice to syngeneic beta 2m+/+ cells.
    Jhaver KG; Rao TD; Frey AB; Vukmanović S
    J Immunol; 1995 Jun; 154(12):6252-61. PubMed ID: 7759863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejection.
    Lamousé-Smith E; Clements VK; Ostrand-Rosenberg S
    J Immunol; 1993 Dec; 151(11):6283-90. PubMed ID: 8245467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells.
    Apasov SG; Sitkovsky MV
    J Immunol; 1994 Mar; 152(5):2087-97. PubMed ID: 8133027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.
    Glas R; Ohlén C; Höglund P; Kärre K
    J Exp Med; 1994 Feb; 179(2):661-72. PubMed ID: 8294874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-thyroid epithelial cell (TEC)-reactive CD8+ T cell lines/clones derived from autoimmune thyroiditis lesions. They recognize self-thyroid antigens directly on TEC to exhibit T helper cell 1-type lymphokine production and cytotoxicity against TEC.
    Sugihara S; Fujiwara H; Niimi H; Shearer GM
    J Immunol; 1995 Aug; 155(3):1619-28. PubMed ID: 7543527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of peptide-specific CD8+ CTL clones in beta 2-microglobulin-deficient mice.
    Cook JR; Solheim JC; Connolly JM; Hansen TH
    J Immunol; 1995 Jan; 154(1):47-57. PubMed ID: 7995959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class I expression.
    Udaka K; Marusić-Galesić S; Walden P
    J Immunol; 1994 Sep; 153(6):2843-50. PubMed ID: 7915743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allospecific cytotoxic T cells generated from beta 2m-/- mice in primary MLC: analysis of activation requirements, specificity, and phenotype.
    Lamousé-Smith E; McCarthy SA
    Cell Immunol; 1997 Aug; 179(2):107-15. PubMed ID: 9268494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 2-microglobulin-dependent T cells are not necessary for alloantigen-induced Th2 responses after neonatal induction of lymphoid chimerism in mice.
    Foucras G; Coureau C; Beijleveld L; Druet P; Saoudi A; Guéry JC
    J Immunol; 1998 Aug; 161(4):1751-7. PubMed ID: 9712040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8 T cells from major histocompatibility complex class II-deficient mice respond vigorously to class II molecules in a primary mixed lymphocyte reaction.
    Shimizu T; Takeda S
    Eur J Immunol; 1997 Feb; 27(2):500-8. PubMed ID: 9045923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
    Beilke J; Johnson Z; Kuhl N; Gill RG
    Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection.
    Tarleton RL; Koller BH; Latour A; Postan M
    Nature; 1992 Mar; 356(6367):338-40. PubMed ID: 1549177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class I is required for peripheral accumulation of CD8+ thymic emigrants.
    Nesić D; Vukmanović S
    J Immunol; 1998 Apr; 160(8):3705-12. PubMed ID: 9558071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of protein kinase C in CD8+ T lymphocyte effector responses.
    Nesic D; Jhaver KG; Vukmanović S
    J Immunol; 1997 Jul; 159(2):582-90. PubMed ID: 9218572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to Listeria monocytogenes in mice lacking MHC class Ia molecules.
    Seaman MS; Pérarnau B; Lindahl KF; Lemonnier FA; Forman J
    J Immunol; 1999 May; 162(9):5429-36. PubMed ID: 10228021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
    Apasov S; Sitkovsky M
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2837-41. PubMed ID: 8464897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice.
    Oliveira SC; Splitter GA
    Eur J Immunol; 1995 Sep; 25(9):2551-7. PubMed ID: 7589125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.